Re: Additional Reports Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Jun 05, 2024 08:46PM
|
Additional Reports Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Jun 05, 2024 07:03AM
|
Re: A Special Meeting of Shareholders?
|
1
|
Resverlogix Corp.
|
May 31, 2024 07:42AM
|
Re: A Special Meeting of Shareholders?
|
|
Resverlogix Corp.
|
May 30, 2024 05:30PM
|
Re: A Special Meeting of Shareholders?
|
|
Resverlogix Corp.
|
May 30, 2024 04:10PM
|
Re: A Special Meeting of Shareholders?
|
|
Resverlogix Corp.
|
May 30, 2024 02:42PM
|
Re: A Special Meeting of Shareholders?
|
1
|
Resverlogix Corp.
|
May 30, 2024 09:57AM
|
Re: A Special Meeting of Shareholders?
|
|
Resverlogix Corp.
|
May 30, 2024 06:07AM
|
Re: A Special Meeting of Shareholders?
|
1
|
Resverlogix Corp.
|
May 29, 2024 07:10AM
|
Re: AGM rescheduled
|
|
Resverlogix Corp.
|
May 28, 2024 05:06PM
|
Re: although pathetic volume's
|
2
|
Resverlogix Corp.
|
May 25, 2024 07:43AM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
May 20, 2024 03:33PM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
May 20, 2024 01:50PM
|
Re: Canadian Securities Administrators
|
1
|
Resverlogix Corp.
|
May 15, 2024 09:41AM
|
Re: 2 year extension
|
1
|
Resverlogix Corp.
|
May 14, 2024 03:35PM
|
Re: Canadian Securities Administrators
|
1
|
Resverlogix Corp.
|
May 14, 2024 02:13PM
|
2 year extension
|
6
|
Resverlogix Corp.
|
May 13, 2024 05:07PM
|
Re: why on earth
|
5
|
Resverlogix Corp.
|
May 13, 2024 03:48PM
|
Re: why on earth
|
1
|
Resverlogix Corp.
|
May 13, 2024 03:20PM
|
Re: why on earth
|
1
|
Resverlogix Corp.
|
May 13, 2024 01:57PM
|